Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for March 19th

Read MoreHide Full Article

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, March 19th:

Cirrus Logic, Inc. (CRUS - Free Report) : This semiconductor company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13% over the last 60 days.

Cirrus Logic, Inc. Price and Consensus

Cirrus Logic has a PEG ratio of 0.86, compared with 3.30 for the industry. The company possesses a Growth Score of A.

Cirrus Logic, Inc. PEG Ratio (TTM)

Mellanox Technologies, Ltd. (MLNX - Free Report) : This fabless semiconductor company, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.

Mellanox Technologies, Ltd. Price and Consensus

Mellanox has a PEG ratio of 0.75, compared with 3.30 for the industry. The company possesses a Growth Score of A.

Mellanox Technologies, Ltd. PEG Ratio (TTM)

TRI Pointe Group, Inc. (TPH - Free Report) : This company that engages in the design, construction and sale of single-family detached and attached homes carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.

TRI Pointe Group, Inc. Price and Consensus

TRI Pointe has a PEG ratio of 0.36, compared with 0.57 for the industry. The company possesses a Growth Score of A.

TRI Pointe Group, Inc. PEG Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.    

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


TRI Pointe Group, Inc. (TPH) - free report >>

Mellanox Technologies, Ltd. (MLNX) - free report >>

Cirrus Logic, Inc. (CRUS) - free report >>